BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook - BioMarin Pharmaceutical
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook BioMarin Pharmaceutical BioMarin to Buy Rare-Disease Biotech Amicus Therapeutics for $4.8 Billion The Wall Street Journal BioMarin CEO says $4.8 billion Amicus deal will lead to cost savings and revenue growth statnews.com BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet CNBC BioMarin is buying Amicus Therapeutics for $4.8 billion Inquirer.com
Latest News
- Fact Sheet: President Donald J. Trump Announces Largest Developments to Date in Bringing Most-Favored-Nation Pricing to American Patients - The White House (.gov)Fact Sheet: President Donald J. Trump Announces Largest Developments to Date in Bringing Most-Favored-Nation Pricing to American Patients The White House (.gov) Trump Announces Pricing Deals With Nine Drugmakers The New York Times Trump announces ‘Most Favored Nation’ deals with nine drug companies, aiming to lower prices for US patients CNN Trump secures agreements with major drugmakers to lower Medicaid prescription costs for Americans Fox Business Nine of the largest pharma companies ink deals with Trump to lower drug prices CNBC
- ByteDance confirms TikTok will be controlled by US owners - Ars TechnicaByteDance confirms TikTok will be controlled by US owners Ars Technica Oracle stock jumps 8% as cloud provider joins investor group to run TikTok's U.S. business CNBC What the deal between TikTok and US investors means for users ABC News China's ByteDance signs deal to form joint venture in step to avoid US TikTok ban Reuters TikTok reaches agreements on new US joint venture with closing set for 2026 Fox Business
- Stock Market Today: Dow Rises; Japan Rate Hike Spurs Bond Yields — Live Updates - The Wall Street JournalStock Market Today: Dow Rises; Japan Rate Hike Spurs Bond Yields — Live Updates The Wall Street Journal The Bank of Japan Raised Rates. Here’s Why You Should Care. The Wall Street Journal Yen Weakens Despite BOJ Hiking Rate to Highest Level Since 1995 Yahoo Finance Japan’s 10-Year Bond Yield Hits 2% for First Time Since 2006 Bloomberg.com Bank of Japan Raises Interest Rates to Highest Level in 30 Years The New York Times
- Quad witching, Nike slides, weed rules and more in Morning Squawk - CNBCQuad witching, Nike slides, weed rules and more in Morning Squawk CNBC Friday could be a wild day of trading on Wall Street. Here's why CNBC Asian Shares to Rise as US CPI Lifts Stocks, Bonds: Markets Wrap Bloomberg.com Friday Is Set for a Record 'Witching' Day The Wall Street Journal Stocks rise as investors brace for potential volatility on quadruple witching day (SPX:) Seeking Alpha
- November home sales struggle as supply stalls - CNBCNovember home sales struggle as supply stalls CNBC US existing home sales edge up in November as mortgage rates ease Reuters Home sales ticked up for third straight month, but the market is still stuck in a deep slump Yahoo Finance NAR Existing-Home Sales Report Shows 0.5% Increase in November National Association of REALTORS® US Existing-Home Sales Edge Up With Help From Tamer Prices Bloomberg.com
- Instacart to Pay $60 Million in Consumer Refunds to Settle FTC Lawsuit Over Allegations it Engaged in Deceptive Tactics - Federal Trade Commission (.gov)Instacart to Pay $60 Million in Consumer Refunds to Settle FTC Lawsuit Over Allegations it Engaged in Deceptive Tactics Federal Trade Commission (.gov) Instacart to pay $60 million in refunds after feds allege it deceived customers CBS News Instacart agrees to refund subscribers $60 million in FTC settlement Ars Technica Instacart shares drop on report that FTC is probing company over AI pricing tool CNBC Instacart settles Federal Trade Commission’s claim it deceived US shoppers Al Jazeera